Evaluate Multiple Regimens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evaluate Multiple Regimens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evaluate Multiple Regimens Today - Breaking & Trending Today

Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in Washington, D.C.

Published: July 19, 2023

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

Source: prnewswire.com

Related Topics:

United StatesSan DiegoMike MoyerIgnacio Guerrero RosRoberte HoffmanDavid SchullNational Cancer InstitutePrnewswire Kintara Therapeutics IncGlobal Coalition For Adaptive Research PhaseCompany Quarterly Reports On FormCompany Annual Report On FormCompany Current Reports On FormGlobal Coalition For Adaptive ResearchGlioblastoma Awareness DayAwareness DayNew Drug ApplicationGlobal CoalitionAdaptive Research PhaseEvaluate Multiple RegimensNewly DiagnosedRecurrent GlioblastomaText ViewAdaptive ResearchPrivate Securities Litigation Reform ActAnnual Report

Kazia Therapeutics : commences recruitment to GBM AGILE

Published: January 7, 2021

ASX RELEASE 7 January 2021 GBM AGILE PIVOTAL STUDY COMMENCES RECRUITMENT TO PAXALISIB ARM Sydney, 7 January 2021 -... | January 27, 2021

Source: marketscreener.com

Related Topics:

New YorkUnited StatesMemorial Sloan Kettering Cancer CenterDana Farber Cancer InstituteNew South WalesIngo MellinghoffIain RossTimothy CloughesyLos AngelesJames GarnerEudociaq LeeTom MikkelsenRegorafenib BayerUniversity Of CaliforniaGlobal Coalition For Adaptive ResearchOncology ConsortiumKazia Therapeutics LimitedAlliance For Clinical TrialsInternational TowersKazia TherapeuticsSt Jude Children ResearchPaxalisib Clinical ProgramCancer CenterHenry Ford Cancer Institute In DetroitPhase Of Development